Introduction
Although disruption of CNS vessel integrity is a hallmark of MS, it is not clear whether such vascular compromise is the initiator or the result of the neuroinflammatory pathophysiology (Lassmann et al., 2007) . Gross vascular compromises have been reported as an early onset indicator in the cerebellum and spine (Floris et al., 2004; Koh et al., 1993; Muller et al., 2005; Tonra et al., 2001) . Current available data, however, does not adequately describe the nature and dynamics of the vessel leak. Previous studies on rats have shown: (1) via radiolabeling, that vessel leaks can be detected in the lower sacral region one day before clinical disease (Koh et al., 1993) and (2) via MRI, vessel leaks in the cerebellum and spine are detected by gadolinium on day 11 preceding macrophage infiltration and onset of clinical disease on day 14 (Floris et al., 2004) . These observations are of major breaches in the vessel integrity, generally in the mm to cm size range. On the other hand, early vascular and associated tissue changes in the pre-symptomatic murine cerebral cortex undergoing EAE pathogenesis are less well defined.
The current dogma dictates that during EAE induction the blood-CNS barrier is rendered "leaky" by irradiation or pertussis toxin (PTx) through histamine-mediated effects (Linthicum et al., 1982) . As engagement of H1R induces microglia activation (Dong et al., 2014) , it is believed that microglia activation occurs during early EAE induction phase (Ponomarev et al., 2005) . However, pathogenic T cell infiltration does not require microglial expression of the major histocompatibility antigen class II (MHCII) molecule , suggesting that another antigen-presenting cell (APC) subset, the dendritic cells (DCs), plays a crucial role in re-activating myelin-specific T cells in the CNS . How circulating DC precursors are attracted to EAE lesions is not entirely clear.
Myelin-specific Th17 and Th1 T cells play critical roles in EAE and MS (Korn et al., 2009 ). Intravital two-photon microscopy (TPM) studies have examined the recruitment and behavior of pathogenic T cells in the mouse brain and spinal cord (Bartholomaus et al., 2009; Flügel et al., 2007; Herz et al., 2011; McGavern and Kang, 2011; Mues et al., 2013; Siffrin et al., 2010) . These investigators focused their observation on T cell behavior during peak clinical symptomatic phase. As such, these studies did not report how such T cells access the brain during the transition from the initiation stage to the infiltration stage of EAE pathogenesis (Lodygin et al., 2013; Odoardi et al., 2012; Sallusto et al., 2012) . However, entry of T cells into the spinal cord in early EAE has been documented previously (Gordon et al., 2001; Kim et al., 2010; Rothhammer et al., 2011) .
Here, we applied sequential TPM to examine cellular behavior at the tissue interface between the subarachnoid space (SAS) and cortex during the first 12 days of asymptomatic induction phase of EAE. We observed transient vessel leaks within the cortical gray matter within the first 3 days of disease induction, which initiated microglia activation, leading to sequential accumulation of DCs followed by myelin-specific T cell infiltration. We further showed that inhibiting histamineinduced microglia activation early in EAE induction could reduce disease progression. Specifically, we described early focal, intermittent and transient disruptions of post-capillary junctional venules following PTx administration, resulting in dextran uptake by the microglia, and immune cellular accumulation. Transient vessel leaks initiated an early parenchymal inflammatory response first evidenced by microglial uptake of blood contents, followed by an influx of both CD11b − APCs. The increasing numbers of activated CNSresident and blood-derived APCs on days 3-6 facilitated the ingress and retention of activated T cells in a myelin-specific manner into the Virchow-Robin Space (VRS) and the parenchyma on days 6-12 before the clinical onset of disease. In contrast to other intravital imaging studies involving the spine, we focused our imaging effort on the cortex, which is relevant to human MS. Interestingly, a distinct pattern of immune cells congregated in patchy tissue niches that were in close proximity to sites of prior microvessel leaks. Early activation of CNS APCs and antigen recognition by T cells in the cortex subsequently affected the pattern of T cell migration in the cerebellum and spine. In addition, we show that histamine H1 receptor antagonist curtailed the frequency of PTx-induced focal vessel leakage, reduced the degree of microglia activation, diminished subsequent recruitment of circulating immune cells, and protected mice from EAE incidence and disease severity.
Materials and methods

Mice
2D2 (Bettelli et al., 2003) mice expressing the TCR transgene specific for MOG35-55 peptide/I-A b (Jackson Labs, #006912) were crossed with B6.129 (ICR)-Tg actin-beta CFP mice (Jackson Labs, #004218) to derive mice expressing 2D2-CFP cells for in vivo tracking by TPM. Similarly, OTII mice expressing the TCR transgene specific for OVA323-339 peptide/I-A b (Taconic, #1896) were crossed with C57BL/6-Tg ubiquitin GFP mice (Jackson Labs, #004353) to derive OTII-GFP cells for in vivo TPM tracking. C57BL/6J, B6.FVB-Tg CD11c-DTR/GFP mice (Jackson Labs, #004509) and B6.129P CX 3 CR1 +/GFP mice (Jackson Labs, #005582) were obtained from Jackson Laboratory. All animals were housed and handled in accordance with protocols approved by the CWRU IACUC.
Active EAE induction
EAE was actively induced in 8-12 week old female mice as previously described (Stromnes and Goverman, 2006 with an emulsion consisting of PBS and CFA. 100 ng pertussis toxin was administered intraperitoneal (i.p.) on days 0, 1 and 2. Daily clinical assessment of mice was performed. Clinical scores were assigned as previously described (Mi et al., 2007; Stromnes and Goverman, 2006) .
Blood brain barrier leakiness analysis
To compare the pattern of vessel leakiness induced by different inflammatory stimulants, 100 ng LPS (Sigma-Aldrich, St. Louis, MO, USA), 100 ng PTx or 200 μL of PBS was injected i.p. into C57BL/6 mice on days 0, 1 and 2. 700 ng of 150 kDa TRITC dextran (Sigma-Aldrich, St. Louis, MO, USA) vessel dye was injected i.v. on day 1 and day 2. On day 3, QTracker-655 (Life Technologies, Grand Island, NY, USA) was injected to highlight the vessels. The mice were sacrificed and whole brain tissues were imaged immediately by TPM.
Priming of antigen-specific T cells
To determine whether myelin specific T cells require antigenspecific APCs for recruitment to the CNS, EAE was actively induced using a combination of two antigenic peptides in 8-12 week old female recipient mice. 3 × 10 6 naïve 2D2-CFP and 3 × 10 6 naïve OTII-GFP CD4 
Flow cytometry analysis
For single-cell APC and T cell characterization, brain tissue was harvested on days 0 through 12 of EAE induction. Tissues were dissociated by collagenase D (1 mg/mL) and DNAse (250 units/mL) (Sigma-Aldrich, St. Louis, MO, USA) to form a single cell suspension after gentle dissociation with a dounce homogenizer and subjected to a 70%/37%/30% Percoll (Sigma-Aldrich, St. Louis, MO, USA) gradient (Cardona et al., 2006) . Isolated cells were stained for CD45, CD11c, CD11b, CD4, CD8, IL-17, IFN-γ and FoxP3. Absolute numbers of cells per brain were determined by multiplying the number of events on FACS per collection volume by the total volume of cell samples. Spleen and LN were isolated from mice at the end of imaging on day 12. Organs were crushed with the ends of 1 mL syringes through a 40-μm cell strainer into single cell suspensions and were stained for Vα2 (OTII TCRα chain), Vβ11 (2D2 TCRβ chain), CD4, CD25, CD44, and CD69. Samples were collected and analyzed using the Accuri flow cytometer (BD Biosciences Co., San Jose, CA, USA).
Tissue histology analysis
After injection of TRITC vessel dye and completion of intravital imaging, CX 3 CR1 +/GFP mice were sacrificed and subjected to transcardial perfusion with 4% PFA. The brain tissue was harvested and 12-μm cryo-sections were performed and the samples were then subjected to confocal microscopy to obtain fluorescent images.
Intravital TMP imaging
Cranial windows were created as previously described (Mostany and Portera-Cailliau, 2008) . The window surgery was performed 4 to 10 days before EAE induction to allow the local surgical site inflammation to subside. On the day of intravital imaging, 150 kDa TRITC dextran or QTracker 655 was injected i.v. 10 min prior to imaging to highlight the vasculature. Image acquisition was conducted using Leica SP5 microscope system on an upright DM6000 stage (Leica Microsystems, Inc.) fitted with a 20× (N.A. 1.0) water immersion lens. The SP5 microscope was coupled with a Ti/sapphire laser (16 W Chameleon XR laser, Coherent, Inc.) tuned to 880 nm to illuminate fluorescent elements within the live tissue. An image volume of 750 × 750 × 150 μm was routinely collected every 30 s to yield xyzt imaging data set.
Hydroxyzine treatment
Oral administration at 5 mg/kg/day was used for treatment with hydroxyzine. For the incidence curve, hydroxyzine was administered via drinking water at a concentration of 0.1 mM starting from day − 1. Later, for FACS and TPM analyses, 5 mg/kg of hydroxyzine was administered via daily gavage from day −1 to day 12.
Imaging data analysis
Second harmonic generation (SHG) signal produced by high collagen content structures was used to identify the pial layer and to discriminate the parenchyma from meninges. Relative fluorescent intensity region of interest (ROI) measurements of dextran leaking into the parenchyma were made using the LAS-AF software (Leica Microsystems Inc., Buffalo Grove, IL, USA). Timing and duration of vessel leaks were manually processed. Cellular dextran uptake and CD11c-GFP were identified by fluorescent intensity. Co-localization of TRITC and GFP signals and volume data were calculated using the Imaris software (BitPlane Inc., Zurich, Switzerland). T cell motility data was also analyzed using the Imaris software, which allows cell identification, as well as 3D tracking over time by producing information on individual positions, time and track length. T cell interactions with APCs were grouped into short contacts (b2 min) and prolonged interactions (≥2 min). Individual T cell migration tracking was further analyzed for track length, velocity, mean fluorescent intensity and cell flux using MATLAB software (Mathworks Inc., Natick, MA, USA). Cell flux was calculated by determining the vector between the beginning of the T cell track and the point at which the T cell came within a 50-μm radius from the center of an APC cluster. Contact time between APC and T cells, and T cell movement to and from the blood vessel were analyzed manually by visual inspection of individual image slices over time using the Imaris software.
Statistical consideration
Statistical analyses were performed using GraphPad Prism 5 software (GraphPad Software Inc., San Diego, CA). For all analyses p b 0.05 was considered significant and degrees of freedom (df) are noted.
Results
Transient focal vessel leaks occurred early in EAE
EAE induction efficiency and clinical presentation can be variable. Therefore, to reliably capture rare cellular events by TPM we introduced fluorescent-labeled naïve 2D2 cells into recipient animals prior to disease induction in combination with a low dose of PTx on the first 3 days of induction without irradiation (Stromnes and Goverman, 2006) . This resulted in 100% disease incidence compared to mice without transferred 2D2 cells (+ 2D2: n = 6 from 2 experiments; − 2D2: n = 20 from 6 experiments), with hind limb paralysis achieved by day 21 (Fig. 1a) . We focused our intravital observation in the cortex during the first 12 days of asymptomatic EAE induction (Luo et al., 2008) . A cranial observation window was surgically implanted 4 to 10 days prior to induction in order to limit the inflammatory changes to structures and cellular response (Barkauskas et al., 2013; Dorand et al., 2014) .
PTx has been shown to disrupt the BBB integrity in EAE (Linthicum et al., 1982) , although the exact location, timing and dynamics of the vessel breach have not been carefully characterized to date. Using TPM and fluorescent-labeled vessel dye, we directly observed focal transient leakage of CNS vascular contents hours to days after PTx injections on days 0 to 2. These transient BBB breaches were visualized as blooms of dye leaking from the vessels ( Fig. 1b; Movie 1) . The effect of PTx on CNS vessel disruption was neither uniform nor permanent, as certain post-capillary venule junctions were prone to intermittent vessel leaks while other vessels of similar caliber remained completely intact (Fig. 1c) . Control mice exhibited little to no vessel leaks (n = 4 from 1 experiment), indicating that these leaks were not due to damages associated with TPM or prior surgical procedures (Figs. 1d and e) . Furthermore, we observed vessel leaks that originated from the vessels outside of the imaging field, arguing against this phenomenon as an artifact of TPM (Movie 2). When the vessel leaks were serially characterized in the same mice through the first 12 days of EAE induction, we observed the highest frequency of vessel leaks during the first 3 days (n = 19 from 8 experiments), coincident with PTx administration (Fig. 1f) . The duration of individual leaks during this early period was variable, with some lasting~30 min before resolving (Fig. 1g) . While vessel content quickly dissipated at the pial surface by the bulk CSF flow in the meningeal space, blood solutes released into the parenchyma took a longer time to clear after resolution of the BBB breach (Fig. 1h) . Evidence of blood persistence can be found deep in the parenchyma, as TRITC-labeled dextran was observed on day 3 in fixed brain tissue (Fig. 1i) .
Identity of TRITC + cells in early EAE
Next, we examined the focal and intermittent nature of the vessel breach by measuring the location and the dextran uptake activity in the cortex throughout EAE induction. CX 3 CR1 is constitutively expressed by the microglia and a sub-population of macrophages in the CNS (Kettenmann et al., 2011) . To identify the TRITC + cells, we induced EAE in Cx 3 cr1 +/GFP mice. Five hours after PTx administration on day 0, the only TRITC + cells in the meninges and parenchyma were 100% CX 3 CR1 + cells (Fig. 2a) .
Intermittent vessel leaks resulted in localized uptake of blood vessel contents by the microglia When TRITC-labeled dextran was introduced intravenously on 3 consecutive days during PTx administration, we observed a patchy distribution of TRITC-labeled cells throughout the parenchyma, while other areas within the same imaging field have little to no detectable TRITC-labeled cells (Fig. 2b) . The distribution of TRITC + cells is consistent with the distribution pattern of transient vessel leaks observed in Fig. 1 . Serial imaging of the same CNS location also revealed that the vessel leaks coincided with observed increase in the TRITC-dextran uptake and activation of the nearby microglia, as judged by morphologic changes (Fig. 2a, inset ), thereby starting a cellular cascade that results in the infiltration and accumulation of circulating immune cells. 
Toxin-dependent phagocytic activation
To assess how the phagocyte distribution may be affected by neuroinflammatory stimuli, we compared the distribution and numbers of TRITC + cells following systemic exposure to PTx and the TLR4 agonist, lipopolysaccharide (LPS). We observed a distinct distribution pattern of parenchymal TRITC + cells between the two stimuli: systemic LPS produced an even distribution of TRITC + cells throughout the entire parenchyma and meninges, whereas PTx treatment resulted in a patchy TRITC + distribution (data not shown) as seen with EAE induction (Fig. 2b) . Both PTx and LPS administration resulted in a significant increase in the appearance of TRITC + cells in both the meninges (PTx, df = 11, p = 0.0082; LPS, df = 8, p = 0.0004) and parenchyma (PTx, df = 11, p = 0.046; LPS, df = 8, p = 0.0009) ( Fig. 2c ; two-tailed unpaired t-test). This method allows serial documentation of the vessel leak patterns in the same hosts with finer time and space resolution than previously reported (Findling et al., 1994) .
CD11c
+ DCs infiltrate the CNS following phagocyte activation CD11c + DCs are required in EAE induction Miller et al., 2007) . To determine the time course of infiltrating DCs and their phagocytic activities in the CNS, we imaged CD11c-GFP + mice daily during the first 12 days of active EAE induction (Fig. 2d) . We quantified the number of CD11c-GFP + cells, TRITC + cells, or both in the meninges and parenchyma ( Fig. 2e ; 1 way ANOVA with df = 41). We observed a significantly increased number of CD11c + TRITC − cells in the meninges starting on days 3 through 12, with increasing dextran uptake from days 9 to 12. The entry of CD11c + TRITC − DCs into the parenchyma was much slower compared to those in the meninges, with DCs increasing in number starting on day 6. Their phagocytic capacity increases over the subsequent 6 days. In contrast, the number of CD11c − TRITC + cells in the meninges decreased between days 3 to 12, even as parenchymal CD11c − TRITC + cell numbers remain constant throughout this period.
Presentation of myelin antigens by CNS APCs enhanced activated myelinspecific T cell entry and retention
Following the characterization of CD11c + and CD11c − APCs in the EAE brain, we investigated the timing and antigen requirement of 2D2 cell recruitment and behavior within the CNS. More 2D2 cells began to infiltrate the brain parenchyma on day 3 and significantly more on day 9 ( Fig. 3a ; n = 5 from 2 experiments, df = 8, p = 0.0082, 1 way ANOVA). However, when mice adoptively transferred with naïve OTII and 2D2 cells were immunized only with OVA323-339, we saw a near complete absence of infiltrating 2D2 or OTII cells in the meninges or the CNS parenchyma (Fig. 3b) , even though both T cell populations were found in equivalent numbers within the peripheral lymph nodes (Fig. 3c ). The few OTII cells resided only transiently in the CNS next to blood vessels and migrated with a reduced speed as compared with 2D2 cells (Fig. 3d) . The divergent behaviors between the two T cell populations were observed in the presence of equivalent leaky CNS vessels, phagocytic APC accumulation and robust T cell activation within the same host. Taken together, our data imply that the cooperation between PTx-induced leaky vessels, resident and infiltrating APCs, the availability of CNS-derived antigens and activated myelin-specific T cells are preconditions for MOG-specific T cell entry into the CNS, which in turn amplifies other cellular infiltration later in the disease progression.
Localized blood vessel leaks preceded phagocyte accumulation and the infiltration of DCs and T cells
To further examine the cellular and structural cooperation leading to EAE, we performed multiplex sequential imaging to capture cellular interactions among TRITC + cells, DCs and 2D2 cells during the first 9 days of EAE induction. Following transient vessel leaks (Fig. 3e, day 4) , the vessel content was cleared with a concomitant increase in the number of TRITC + cells and the arrival of CD11c + DCs by day 6 (Fig. 3e, days 6-9). This was followed on day 9 by a large number of infiltrating 2D2 cells that congregated near sites of previous vessel leaks (Fig. 3e, day  9) , eventually leading to extensive inflammatory changes, with tail and limb weakness beginning on days 10 onward (Fig. 1a) . The 2D2 cells surveyed a large parenchymal area, while maintaining focal movements surrounding sites of prior vessel leak where clusters of CD11c + cells were also found (Fig. 3e , day 9 tracks; Movie 3). The 2D2 cells exhibited both transient (b2 min) and prolonged (≥2 min) contacts with DCs (Fig. 3f) . Those 2D2 cells that interacted briefly with CD11c + DCs migrated at faster velocities (~14.8 ± 4.2 μm/min), while those that exhibited prolonged interaction with DCs traveled with reduced velocities (~12.5 ± 3.6 μm/min) (Fig. 3g) . In all, 83% of 2D2 cells were motile, with 6.1 ± 5.1% of 2D2 cells residing in the perivascular areas with limited motility.
2D2 cells preferentially congregated in DC-rich regions
To assess whether 2D2 cells were preferentially drawn to sites of DC aggregates, we analyzed the number of 2D2 cells entering a 50-μm radius of a CD11c + -GFP + cellular aggregate. Our analysis revealed a significant increase in the number of unique 2D2 cells moving toward an area high in GFP signals as compared to areas with low GFP signals within the same imaging field ( Fig. 3h ; n = 5 from 2 experiments, df = 21, p = 0.0069, two-tailed unpaired t-test). Contact duration analysis of 2D2 cells with CD11c + and CD11c − phagocytes showed a trend toward longer duration of contact with CD11c + cells ( Fig. 3i ; n = 5 from 2 experiments, df = 17, p value not significant, 1 way ANOVA). We also found a trend for a greater number of 2D2 cells egressing from nearby blood vessels to enter the CD11c + rich regions as compared to those entering the vessels from the parenchyma ( Fig. 3j ; Movies 4, 5; n = 5 from 2 experiments, df = 24, p value not significant, two-tailed unpaired ttest).
Histamine H1 receptor blockade reduced microglia activation, DC recruitment, disease incidence and clinical severity
Histamine released by mast cells is implicated in PTx-mediated vessel leak (Linthicum et al., 1982) . We tested whether blockade of the histamine H1 receptor (H1R) could ameliorate observed vessel leak and subsequent cellular accumulation events. We administered hydroxyzine (HXYZ), a H1R antagonist that readily crosses the BBB, in the drinking water of mice undergoing EAE induction. We observed a 60% reduction in EAE incidence among mice receiving HXYZ treatment ( Fig. 4a ; n = 10 from 2 experiments). Despite HXYZ treatment via gavage, however, we still observed PTx-induced vessel leaks (Figs. 4b, c ; Movie 6). Nevertheless, HXYZ treatment did result in a dramatic reduction in the number of TRITC + parenchymal cells, with numbers comparable to PBS control ( Fig. 4d ; PBS: PTx + HXYZ, df = 7, p value not significant, two-tailed unpaired t-test). These findings were further 
CD11c
− macrophages ( Fig. 4g ; df = 12, p = 0.0049, two-tailed unpaired t-test), as well as a similar reduction in the number of infiltrating CD8 + ( Fig. 5a ; df = 8, p = 0.0013, two-tailed unpaired ttest) and CD4 + T cells ( Fig. 5b ; df = 8, p = 0.0005, two-tailed unpaired t-test) in HXYZ-treated groups early on day 3. This was accompanied by a reduced number of CNS infiltrating IL-17 and IFN-γ producing CD4 + T cells (Fig. 5c, day 9 ; IL-17: df = 8, p = 0.036; IFN-γ: df = 8, p = 0.024; two-tailed unpaired t-test), even though the spleens of these mice contained similar numbers of IL-17 and IFN-γ producing CD4 + T cells (Fig. 5d) .
Discussion
CNS vessel leak has been implicated as a trigger in neurodegenerative disorders including epilepsy, Alzheimer, and Parkinson's disease (Hawkins and Davis, 2005; Zlokovic, 2011) . Although changes in CNS vessel permeability have been documented in vivo, the timing and kinetics at the level of detail as described in the current study has not been reported previously (Davalos et al., 2012; Findling et al., 1994; Kenne and Lindbom, 2011; McGavern and Kang, 2011) . We provided evidence of the transient and focal nature of altered vascular permeability in early EAE induction as an initiating event, not a byproduct of effector T cell aggregation and tissue destruction near the perivascular pathologic lesions. These leaks occurred during PTx treatment, where blood contents including plasma proteins and fibrinogen (Davalos et al., 2012) are released into the parenchyma and initiate a parenchymal inflammatory response including the activation of the phagocytic capacity of resident CX 3 CR1 + microglia (Neumann et al., 2009) , well in advance of any observable clinical symptoms. Vessel leaks were found in the meninges and throughout the parenchyma. During the early vessel leaks following PTx administration, we did not detect influx of circulating monocytes or T cells in the cortex, suggesting that the opening of the BBB at this stage does not permit a large influx of circulating cells into the imaged region of the brain. At later time points (days 4-6) when the vessel leakage subsides, we began to observe increasing immune cell infiltrate coincident with a second wave of vessel leak (Figs. 1d, e; days 7-9), an observation consistent with the two-step paradigm of EAE induction (Sallusto et al., 2012) . Interestingly, while PTx administration resulted in focal dextran-uptake activity, systemic administration of LPS, the classical TLR4 agonist, resulted in a diffuse pattern of dextran uptake in the CNS presumably due to the direct effect of LPS on endothelial and immune cells throughout the body (Andonegui et al., 2003 (Andonegui et al., , 2009 ). The observed differential effects between PTx and LPS on CNS dextran uptake are interesting, since PTx has been shown to evoke intracellular signaling through TLR4 (Kerfoot et al., 2004) . Mice with functionally deficient microglia exhibited delayed EAE onset and reduced severity, suggesting microglia contribution in EAE pathogenesis Heppner et al., 2005) . Peritoneal macrophages activated with ConA display increased pinocytosis concomitant with an increase in phagocytosis, and prolonged pinocytosis may be an indicator of macrophage activation (Cohn, 1966) . Depending on the mode of activation, however, pinocytosis may also decrease as compared to non-activated macrophages (Montaner et al., 1999; Tsang et al., 2000) . Pinocytosis is a highly metabolic process and requires an ATP source such as dextran (Edelson et al., 1975) . In our study, we found that the microglia surrounding the vessel leaks were pinocytic. Using the CX 3 CR1 +/GFP reporter mouse, we showed that the microglia and macrophages constitute the main pinocytic populations that absorb vessel contents in the first 3 days. These cells can internalize vessel contents in response to TLR agonist stimulation by one of two ways. First, they act as scavengers, removing blood solutes following vessel leaks. Second, perivascular CX 3 CR1 + cells can sample blood contents directly within intact blood vessels through intravascular processes (Barkauskas et al., 2013) . Bone marrow derived myeloid cells are also important in regulating CNS inflammatory response, where infiltrating DCs with functional MHCII are required for EAE induction Greter et al., 2005; Heppner et al., 2005; Juedes and Ruddle, 2001; Miller et al., 2007; Pashenkov et al., 2003; Serafini et al., 2000) . Activated OTII cells can access the CNS only in the presence of co-activated 2D2 cells. In contrast, activated OTII cells in the presence of naïve 2D2 cells were incapable of doing so, despite the presence of pinocytic microglia and DCs. These results suggest that T cells do not simply enter CNS passively through disrupted BBB but require activated 2D2 cells recognizing myelin-presenting APCs. Our data support the view that APCs presenting endogenous CNS peptides are critical to license T cell recruitment and retention in the EAE brain. Our TPM imaging and FACS data are in good agreement with reports showing that 5-10% of CD11b + cells present myelin basic protein as early as day 1 after EAE induction, whereas CD11c + DCs are not detected till after day 5 and only present myelin basic protein from day 7 onwards (Sosa et al., 2013) . T cell infiltration into the brain was thought to only occur at the choroid plexus, although recent data suggest an alternate route via VRS and the pial vessels in the SAS (Goverman, 2009; Ransohoff and Engelhardt, 2012) . Our imaging data captured T cells migrating directly into the parenchyma from VRS, and migrated near CD11c + DCs in a pattern that were in contrast to published data showing non-directed T cell behavior during the peak of EAE disease (Bartholomaus et al., 2009; Herz et al., 2011; McGavern and Kang, 2011; Mues et al., 2013; Siffrin et al., 2010) . Our finding of the focal T cell accumulation and their repeated surveillance with DCs during the asymptomatic phase of EAE suggests direct communication between newly arrived 2D2 and DCs. These short contacts were similar to other reports, which utilized calcium flux and NFAT reporter mice to show that infiltrating T cells in the spine of passively induced EAE mice were in an activated state while meandering and making short contacts with phagocytic APCs (Lodygin et al., 2013; Mues et al., 2013) . Here, we showed that 2D2 cells are re-activated by DCs in the cortex before these T cells exert their pathogenic effector function, eventually leading to the development of clinical symptoms. PTx has been shown to increase the permeability of vessels (Linthicum et al., 1982; Locht et al., 2011; Miyata and Morita, 2011) with direct effects on the choroid plexus and cerebral endothelial cells (Brückener et al., 2003; Lapilla et al., 2011) . In the brain, PTx is postulated to act through histamine, which causes vasodilation, changes adhesion molecule expression, and alters endothelial tight junctions and astrocyte end feet barrier integrity. Mice deficient in histamine receptors 1 and 2 have reduced EAE severity and BBB permeability (Saligrama et al., 2012) . The CSF of MS patients contains elevated levels of histamine, and H1R antagonists have shown clinical benefits in MS (Jadidi-Niaragh and Mirshafiey, 2010) . In a clinical trial, hydroxyzine was shown to stabilize or improve symptoms in 75% of MS patients (Logothetis et al., 2005) .
Interestingly, we only observed a trend toward diminished frequency, but not a complete absence of vessel leakage when HXYZ was administered. Our observation suggests that mechanism(s) other than histamine are responsible for vessel permeability changes under neuroinflammatory conditions, such as tachykinins (e.g. substance P), serotonin, and bradykinin (Annunziata et al., 1998 (Annunziata et al., , 2002 Feng et al., 1996; Kakizoe et al., 1997; Olesen, 1985; Reinke et al., 2006; Saria et al., 1983) . Regardless, we showed that HXYZ treatment reduced EAE disease incidence or severity in 60% of the mice. Furthermore, HXYZ initially reduced the extent of dextran uptake by meningeal macrophage as documented by TPM and decreased the myeloidderived APC infiltration globally in the CNS. Importantly, preventing the early activation of the microglia with HXYZ resulted in a reduction of both non-specific T cell infiltration on day 3 and antigenspecific T cell infiltration on day 12. These data provide further evidence supporting the view that the microglia play critical roles in early EAE induction, and that blocking microglia activation during the inflammatory phase can lessen myelin and neuronal destruction (Giunti et al., 2013; Juedes and Ruddle, 2001; Saijo and Glass, 2011) . Future work remains to fully understand the regulation of focal and intermittent CNS vessel disruption that was only partially blocked by H1R blockade.
The exact kinetics of cellular inflammation in the brain have been hard to study, especially during the very early stages of EAE induction prior to disease manifestation, due to the low number of relevant cells detected using conventional bulk cellular assays. Our present study helps to shed new light on the precise, local and sequential interplay among CNS tissues and cellular factors that coordinately manifest in early EAE pathophysiology involving early intermittent BBB disruption, local activation of the microglia, subsequent recruitment of DCs, and the surveillance behavior of pathogenic CD4 + T cells in the EAE brain. Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.expneurol.2015.02.018.
